← Back to Screener
NuCana plc American Depositary Share (NCNA)
Price$1.95
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-62.36%
Price vs S&P 500 (4W)-7.57%
VGM Score29.15
Market Capitalization$11.25M
All Metrics
Book Value / Share (Quarterly)$0.00
P/TBV (Annual)0.50x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.00
Price vs S&P 500 (YTD)-53.99%
EPS (TTM)$-0.01
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-0.01
EPS (Annual)$-0.00
ROI (Annual)-117.40%
Cash / Share (Quarterly)$0.00
ROA (Last FY)-98.39%
EBITD / Share (TTM)$-0.00
ROE (5Y Avg)-154.07%
Cash Flow / Share (Annual)$-0.00
P/B Ratio0.28x
P/B Ratio (Quarterly)0.20x
Net Income / Employee (Annual)$-3,929,004
Net Interest Coverage (TTM)-1.46x
ROA (TTM)-116.11%
EPS Incl Extra (Annual)$-0.00
Current Ratio (Annual)5.60x
Quick Ratio (Quarterly)5.29x
3-Month Avg Trading Volume0.04M
52-Week Price Return-75.32%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.00
52-Week High$40.00
EPS Excl Extra (Annual)$-0.00
CapEx CAGR (5Y)-34.75%
Tangible BV CAGR (5Y)-25.20%
26-Week Price Return-54.44%
Quick Ratio (Annual)5.45x
13-Week Price Return-0.52%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)5.48x
Enterprise Value$-19.47M
Book Value / Share Growth (5Y)-77.18%
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.00
3-Month Return Std Dev90.22%
Net Income / Employee (TTM)$-4,115,328
ROE (Last FY)-120.66%
EPS Basic Excl Extra (Annual)$-0.00
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$-0.01
ROI (TTM)-150.62%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.00
Price vs S&P 500 (52W)-99.68%
Year-to-Date Return-45.83%
5-Day Price Return-10.14%
EPS Normalized (Annual)$-0.00
ROA (5Y Avg)-86.72%
Month-to-Date Return-16.31%
Cash Flow / Share (TTM)$-1.12
EBITD / Share (Annual)$-0.00
LT Debt / Equity (Annual)1.03x
ROI (5Y Avg)-150.14%
LT Debt / Equity (Quarterly)1.02x
EPS Basic Excl Extra (TTM)$-0.01
P/TBV (Quarterly)0.22x
P/B Ratio (Annual)0.45x
Book Value / Share (Annual)$0.00
Price vs S&P 500 (13W)-8.77%
Beta2.24x
Revenue / Share (TTM)$0.00
ROE (TTM)-153.72%
52-Week Low$1.33
mGradeD
vgmGradeD
Show chart for
Analyst Recommendations
Mar 2025
Apr 2025
May 2025
Jun 2025
4.00
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NCNANuCana plc American Depositary Share | — | — | D | $1.95 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
NuCana PLC is a biopharmaceutical company developing cancer treatments based on its proprietary ProTide technology, which delivers higher concentrations of anti-cancer metabolites to tumor cells to overcome drug resistance. The company's pipeline comprises three candidates—NUC-3373, NUC-7738, and Acelarin—with primary operations in the United States.